ArticleProtein science : a publication of the Protein Society2026
Engineering a protein homodimer from a heterodimer: A chimeric DBHS protein.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering a protein homodimer from a heterodimer: A chimeric DBHS protein.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Drosophila behavior/human splicing (DBHS) proteins are involved at nearly every stage of the RNA lifecycle. There are three paralogues in mammals-SFPQ, NONO and PSPC1-which form both homodimer and heterodimers. It is likely that the non-redundant and overlapping roles of the different DBHS paralogues emerge from their dynamic and combinatorial nature; that is, their ability to mix and match dimer partners. A strong preference for heterodimerisation over homodimerisation has been demonstrated. However, the underlying molecular determinants of DBHS partner preference are poorly understood. This study describes the design, and biochemical and structural characterization of a chimeric DBHS protein designed to be a homodimer with an interface that emulates a DBHS heterodimer. In vitro experiments show that this chimera indeed remains as a homodimer even when in the presence of a native DBHS protein that prefers heterodimerisation. The ease of purification, production of high-quality crystals for X-ray diffraction, and perfect crystallographic symmetry of this engineered homodimer presents this as an attractive approach for future structural studies on DBHS proteins. This ability to engineer partner preference also highlights the potential for DBHS proteins to serve as versatile building blocks in synthetic biology. Furthermore, comparison of the dimer interface of this engineered homodimer with native DBHS proteins highlights subtle conformational differences in residues at the core of the dimer interface, indicating that maximized packing of a core tryptophan residue combined with increased hydrophobic or polar complementarity at the interface is likely to determine DBHS partner preference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.